ФАКТОРЫ РИСКА ДО И ПОСЛЕОПЕРАЦИОННЫХ ОСЛОЖНЕНИЙ ПРИ ИНТРА-ЭКСТРАКРАНИАЛЬНОМ АТЕРОСКЛЕРОТИЧЕСКОМ ПОРАЖЕНИИ АРТЕРИЙ
2023 жыл | Шығарылым: 4 | Беттер: 67-76
POPULATION FEATURES OF THE GENETIC MARKER’S DISTRIBUTION OF THE HEART FAILURE EFFECTIVENESS THERAPY WITH SGLT2 INHIBITORS IN THE KAZAKH POPULATION
2023 жыл | Шығарылым: 4 | Беттер: 49-58
THE ISSUES OF DRUG INTERACTION IN COMBINATION PHARMACOTHERAPY IN CARDIOLOGICAL PRACTICE
2023 жыл | Шығарылым: 4 | Беттер: 42-48
ПРОСПЕКТИВНОЕ ИССЛЕДОВАНИЕ РОЛИ ДЕФИЦИТА ВИТАМИНА D У ДЕТЕЙ, РОЖДЕННЫХ С МАКРОСОМИЕЙ
2023 жыл | Шығарылым: 3 | Беттер: 152-158
ОЦЕНКА ВЛИЯНИЯ ПОЛИМОРФИЗМА ГЕНА АВСВ1 НА ФАРМАКОКИНЕТИЧЕСКИЕ ПАРАМЕТРЫ АПИКСАБАНА В КАЗАХСКОЙ ПОПУЛЯЦИИ
2023 жыл | Шығарылым: 3 | Беттер: 32-39
РОЛЬ ДЕМОГРАФИЧЕСКИХ И СОЦИАЛЬНЫХ ФАКТОРОВ В ДИАГНОСТИКЕ И ПРОФИЛАКТИКЕ COVID-19: ИССЛЕДОВАНИЕ В ГОРОДЕ СЕМЕЙ
2025 жыл | Шығарылым: 2 | Беттер: 124-133
ANALYSIS OF ANTIBIOTIC PRESCRIBING PRACTICES IN PRIMARY HEALTH CARE SETTINGS. PART I
2025 жыл | Шығарылым: 2 | Беттер: 134-144
GENETIC SUSCEPTIBILITY TO RADIATION-RELATED DISEASES: A REVIEW OF CURRENT LITERATURE
2025 жыл | Шығарылым: 2 | Беттер: 145-153
ТЕНДЕНЦИИ ЗАБОЛЕВАЕМОСТИ ИНФЕКЦИОННОГО ЭНДОКАРДИТА ПОСЛЕ ОБНОВЛЕНИЯ МЕЖДУНАРОДНЫХ РУКОВОДСТВУЮЩИХ ПРИНЦИПОВ. ОБЗОР ЛИТЕРАТУРЫ.
2025 жыл | Шығарылым: 2 | Беттер: 154-167
СРАВНЕНИЕ МЕТОДОВ МОДЕЛИРОВАНИЯ РЕЦЕССИИ ДЕСНЫ НА ЛАБОРАТОРНЫХ ЖИВОТНЫХ
2025 жыл | Шығарылым: 2 | Беттер: 168-178
CLINICAL MANIFESTATIONS OF CHLAMYDIA INFECTIONS IN WOMEN
Chlamydia is one of the most widespread diseases, sexually transmitted infections. Every year in the world suffered from chlamydial infection of about 90 million people. It accounts for up to 1/2 of all vul′vovaginal′nyh of the lower genital tract infections Division. The clinical picture is characterised by a secretive process of infectious hlamidijnogo and malosimptomnost′û. Because of the unique development cycle and intracellular parasitism Chlamydia has a tendency to chronic diseases and complications such as infertility.
Толығырақ
2012 жыл | Шығарылым: 1 | Беттер: 57-58
LABORATORY DIAGNOSTICS CHLAMYDIA INFECTIONS
Author had been improved a microscopic method of diagnostics urogenital chlamidiosis, by addition of 2 % DMSO, allowed to increase sensitivity of a method to 30 %.
Толығырақ
2012 жыл | Шығарылым: 1 | Беттер: 57-58
APPLICATION RONCOLEUKIN TREATMENT OF GENITAL HERPES
Ronkoleikin is describet in the article like high effective and safe medical remedy for Herpes genitalis treatment. This remedy doesn`t cause any complications and may be recommended for broad using.
Толығырақ
2012 жыл | Шығарылым: 1 | Беттер: 55-57
POLYMERASE CHAIN REACTION IN DIAGNOSTICS OF VIRAL URINOGENITAL INFECTIONS
The presented results of studies using PCR have shown that the frequency of detection of Human Papilloma Virus 16/18 type of the examined patients was 10%. The authors believe that PCR analysis should be used in the diagnosis of PVI as the screening because it can be used reliably in short time to obtain the results for large groups of examinees. However, in many cases, the positive result of HPV DNA studies indicate only the presence of infection, but will not reliably predict the development of cervical cancer.
Толығырақ
2012 жыл | Шығарылым: 1 | Беттер: 53-55
THE RELEVANCE EPIGEN AND VIUSID REVEALED OF STUDYING GENITAL HERPETIC INFECTIONS OF WOMEN AT REPRODUCTIVE AGE
The relevance of studying genital herpetic infections of women at reproductive age has a high social and medical im-portance. Development of effective treatment methods of genital herpes is one of the main stages for solving the problem of effective treatment of patients with recurrent genital herpes. Conducted complex treatments using Epigen and Viusid revealed a statistically significant three time increase of clinics duration, decrease of relapse period, had a positive effect on laboratory features alignment of secondary immune dysfunctions of patients with herpetic viral infections.
Толығырақ
Толығырақ
2012 жыл | Шығарылым: 1 | Беттер: 52-53